# EDGAR Filing Document

**Accession Number:** 0001871321
**File Stem:** 0001213900-25-059491
**Filing Date:** 2025-6
**Character Count:** 2377
**Document Hash:** 8235e02f313b8bb88e30add117c3d8e9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-059491.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001213900-25-059491

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Alpha Tau Medical Ltd.
- **CENTRAL INDEX KEY:** 0001871321
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605
- **BUSINESS PHONE:** 972-3-577-4115

**MAIL ADDRESS:**
- **STREET 1:** KIRYAT HAMADA 5
- **CITY:** JERUSALEM
- **STATE:** L3
- **ZIP:** 9777605

June 30, 2025

**<u>Via EDGAR Transmission</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Industrial Applications and Services

100 F Street, N.E.

Washington, D.C. 20549

Attention: Margaret Sawicki

---

| | |
|:---|:---|
| **Re:** | **Alpha Tau Medical Ltd.** |
|  | **Registration Statement on Form F-3** |
|  | **Filed June 23, 2025** |
|  | **File No. 333-288240** |

---

Ladies and Gentlemen:

In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on July 2, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the "***Company***") or its counsel may request via telephone call to the staff. Please contact Nathan Ajiashvili of Latham & Watkins LLP, counsel to the Company, at +1.212.906.2916, or in his absence, Joshua G. Kiernan at +44.20.7710.5820, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.

[*Signature Page Follows*]

---

| | |
|:---|:---|
| Sincerely yours, | Sincerely yours, |
| **Alpha Tau Medical Ltd.** | **Alpha Tau Medical Ltd.** |
| By: | /s/ Uzi Sofer |
|  | Uzi Sofer |
|  | Chief Executive Officer |

---

cc: Nathan Ajiashvili, Esq.

[Signature Page to Acceleration Request]